Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06140719 · ClinicalTrials.gov registry record

xPedite: A Study to Expedite DIPG and DMG Research

A clinical trial of Oncology and DIPG, sponsored by xCures.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT06140719 is a study of Oncology and DIPG that is actively recruiting participants, run by xCures. The registered enrollment target is 400 participants, below the 511-participant average among 24 other Oncology trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06140719, a study of Oncology and DIPG, is actively recruiting participants, sponsored by xCures.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development programs of drugs, devices, or biologic interventions in DMG or DIPG.

Conditions Studied

Study Locations (1)

California

  • xCures, Inc. - Los Altos

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-11-01
Est. Completion 2027-01

Sponsor

xCures

4 total trials

What the Registry Record Tells You About NCT06140719

The ClinicalTrials.gov registry entry for NCT06140719 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 511-participant average among 24 other Oncology trials with a reported enrollment target (22% lower). The listed sponsor is xCures, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Oncology appearing as the primary indexed condition, and to 0 interventions.

NCT06140719 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06140719 about?

NCT06140719 is a clinical study titled "xPedite: A Study to Expedite DIPG and DMG Research". This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development progr...

What is the current status of trial NCT06140719?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2023-11-01. Estimated completion is 2027-01.

What conditions does trial NCT06140719 study?

This clinical trial studies the following conditions: Oncology, DIPG, DMG.

Who is sponsoring clinical trial NCT06140719?

This trial is sponsored by xCures, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06140719 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oncology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.